Home / Expertise / Life Sciences & Healthcare
laboratory shelfs with bottles and vials

Life Sciences & Healthcare

Germany

The CMS Life Sciences und Healthcare Sector Group is made up of over 50 lawyers across Europe, many of whom have specialised in the Life Sciences und Healthcare industry for several years.

The essence of the group's approach is teamwork, working closely as colleagues in Western and Central Europe. The group has complementary expertise in pharmaceutical, biotechnology, medical device, diagnostic and related areas, so can offer pan-European and local, national advice and assistance to the Life Sciences und Healthcare industries.

The group is recognised as having centres of excellence in respect of pharmaceuticals and medical devices in its practices in the United Kingdom, the Netherlands and Germany as well as specialist tax expertise in France.

Services

The CMS Life Sciences und Healthcare Sector Group provides the following comprehensive range of services:

  • Regulatory
  • Pre-clinical and clinical research
  • Collaboration and licensing
  • Financing/M&A stock option schemes
  • Business restructuring
  • Strategic alliances, mergers and acquisitions
  • Distribution and parallel import issues
  • Patent protection and enforcement
  • Branding, trade dress, advertising and labelling
  • Media issues
  • Personal data
  • Product liability and litigation
  • Health and safety
  • EC & competition/competition enforcement
  • Public sector tendering
  • Environment
  • Immigration

Contact

For further information on CMS Life Sciences und Healthcare Sector Group please contact Mr. Jens Wagner.

We are strategic partners of

Young Excellence in healthcare

Young Excellence in Healthcare (YEH) is an interdisciplinary network bringing together young professionals from the healthcare sector. It seeks to develop an intelligent framework for delivering health services in the world of tomorrow. CMS Germany advises YEH strategically and exclusively on all legal matters. CMS also acts as a sounding board for the legal issues and healthcare policies YEH wishes to promote.

Read more Read less

Law Firm of the Year for Healthcare

JUVE Guide, 2018/2019
05 September 2019
CMS Life Sci­ences & Health­care Glob­al Bro­chure
With more than 300 law­yers, pat­ent at­tor­neys, sci­ent­ists and aca­dem­ics’ across CMS and the sup­port of the Life Sci­ences Asia-Pa­cific Net­work (LAN), we un­der­stand the sci­entif­ic and com­mer­cial as well...

Feed

Show only
14 May 2021
Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice
Doc­u­ment sign­ing has presen­ted nov­el chal­lenges in the new re­mote-work­ing en­vir­on­ment. Re­cord­ing an as­sign­ment at the European Pat­ent Of­fice (EPO) can be straight­for­ward provided that the form­al re­quire­ments...
04 May 2021
With Il­lu­mina ac­tion, court to test EU Com­mis­sion's new mer­ger re­fer­ral...
On 29 April 2021, the US life sci­ences com­pany Il­lu­mina con­firmed that it filed an ac­tion be­fore the EU courts ask­ing for an an­nul­ment of the European Com­mis­sion’s de­cision of 19 April 2021 to ac­cept...
20 April 2021
COV­ID-19 vac­cin­a­tion and test­ing in Ger­many - em­ploy­ment law per­spect­ive
Vac­cin­a­tion 1. What op­tions does the em­ploy­er have to en­cour­age em­ploy­ees to be vac­cin­ated? Can the em­ploy­er provide a fin­an­cial in­cent­ive to em­ploy­ees?  The em­ploy­er can al­ways raise aware­ness and...
Comparable
06 April 2021
EU is­sues draft of Di­git­al Mar­kets Act aimed at cre­at­ing a new and fair...
The European Com­mis­sion has pub­lished a draft pro­pos­al for a new com­pet­i­tion law frame­work for large on­line plat­forms, called the Di­git­al Mar­kets Act (DMA). The Com­mis­sion pro­posed the DMA due to the...
23 March 2021
On the Pulse
Wel­come to ‘On the Pulse’ de­livered by the Glob­al Life Sci­ences & Health­care Sec­tor Group A video/pod­cast series, On the Pulse, brings to­geth­er CMS law­yers and ex­perts to dis­cuss key in­dustry top­ics...
23 March 2021
The En­larged Board of the European Pat­ent Of­fice has giv­en a mo­ment­ous...
The En­larged Board of the European Pat­ent Of­fice heard or­al ar­gu­ments in Ju­ly 2020 con­cern­ing pat­entab­il­ity of a com­puter soft­ware in­ven­tion.  This rare event was video streamed to over 1600 pat­ent stake­hold­ers...
05 March 2021
New EPO Guidelines on an­ti­body claims provide fur­ther clar­ity for ap­plic­ants
In­tro­duc­tion The EPO has now pub­lished their re­vised Guidelines for Ex­am­in­a­tion 2021[1] which con­tain new sec­tions de­tail­ing EPO prac­tice in re­la­tion to an­ti­bod­ies for the first time, en­ter­ing in­to force...
25 March 2021
European Can­nabis Con­fer­ence
The con­fer­ence will com­prise high-in­terest pan­el dis­cus­sions at the fore­front of the grow­ing can­nabis sec­tor. Key pan­el top­ics will in­clude the European Can­nabis Land­scape, Chal­lenges & Op­por­tun­it­ies...
24 February 2021
COV­ID and ViCo: EPO re­fer­ral to the En­larged Board of Ap­peal
In the last year, the COV­ID-19 pan­dem­ic has res­ul­ted in a large pro­por­tion of the leg­al sec­tor trans­ition­ing to a ‘work from home’ ar­range­ment, with meet­ings tak­ing place re­motely. Non-es­sen­tial travel...
16 February 2021
Fight­ing poor med­ic­a­tion ad­her­ence in the European Uni­on: The Grav­it­ate-Health...
Nowadays, European cit­izens can ob­tain a great amount of in­form­a­tion (on­line and off­line) about any medi­cine. However, this in­form­a­tion is in many cases un­re­li­able and dif­fi­cult to un­der­stand, en­cour­aging...
03/02/2021
CMS ad­vises DRK Fulda on set­ting up coronavir­us vac­cin­a­tion centres
Frank­furt/Main – The Fulda branch of the Ger­man Red Cross (DRK) is start­ing op­er­a­tion of two vac­cin­a­tion centres in the fed­er­al state of Hesse, to­geth­er with a num­ber of loc­al part­ners.An in­ter­dis­cip­lin­ary...
13 January 2021
EU­'s Por­tuguese pres­id­ency re­leases new draft of ePri­vacy Reg­u­la­tion
On 5 Janu­ary 2021, the Coun­cil of the EU – with Por­tugal serving as the Pres­id­ent-in-Of­fice – re­leased a new draft ver­sion of the ePri­vacy Reg­u­la­tion, which is meant to re­place the ePri­vacy Dir­ect­ive...